{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:10:51Z","timestamp":1791929451676,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","oooojournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.oooo.2017.10.010","type":"journal-article","created":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T21:19:01Z","timestamp":1510003141000},"page":"157-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Medication related osteonecrosis of the jaws associated with targeted therapy as monotherapy and in combination with antiresorptives. A report of 7 cases from the Copenhagen Cohort"],"prefix":"10.1016","volume":"125","author":[{"given":"Hoda","family":"Abel Mahedi Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte Emilie Nor","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Schiodt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oooo.2017.10.010_bib0010","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2217\/fon.13.211","article-title":"Epidemiology, clinical manifestations, risk reduction and treatment strategies of jaw necrosis in cancer patients exposed to antiresorptive agents","volume":"10","author":"Campisi","year":"2014","journal-title":"Future Oncol"},{"key":"10.1016\/j.oooo.2017.10.010_bib0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bjoms.2014.09.001","article-title":"Up to a quarter of patients with osteonecrosis of the jaw associated with antiresorptive treatment remain undiagnosed","volume":"53","author":"Fedele","year":"2015","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2017.10.010_bib0020","series-title":"Contemporary Nordic Odontology","first-page":"61","article-title":"Osteonecrosis of the jaws\u2014a severe side effect of antiresorptive treatment","author":"Schiodt","year":"2015"},{"key":"10.1016\/j.oooo.2017.10.010_bib0025","doi-asserted-by":"crossref","first-page":"206","DOI":"10.5125\/jkaoms.2014.40.5.206","article-title":"Drug holiday as a prognostic factor of medication-related osteonecrosis of the jaw","volume":"40","author":"Kim","year":"2014","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2017.10.010_bib0030","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10006-012-0379-9","article-title":"Osteonecrosis of the mandible due to anti-angiogenic agent, bevacizumab","volume":"17","author":"Pakosch","year":"2013","journal-title":"Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2017.10.010_bib0035","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/j.oooo.2013.02.001","article-title":"Osteonecrosis of the mandible associated with bevacizumab therapy","volume":"115","author":"Santos-Silva","year":"2013","journal-title":"Oral Surg Oral Med Oral Path Oral Radiol"},{"key":"10.1016\/j.oooo.2017.10.010_bib0040","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.joms.2011.02.104","article-title":"Osteonecrosis after administration of intravitreous bevacizumab","volume":"70","author":"Hopp","year":"2012","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2017.10.010_bib0045","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxiollofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2017.10.010_bib0050","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00520-017-3629-4","article-title":"Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors","volume":"25","author":"Vigarios","year":"2017","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.oooo.2017.10.010_bib0055","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.tripleo.2011.06.023","article-title":"Sunitinib related osteonecrosis of jaw: a case report","volume":"113","author":"Fleissig","year":"2012","journal-title":"Oral Surg Oral Med Oral Path Oral Radiol"},{"key":"10.1016\/j.oooo.2017.10.010_bib0060","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1080\/14740338.2016.1177021","article-title":"Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology","volume":"15","author":"Fusco","year":"2016","journal-title":"Exp Opin Drug Saf"},{"key":"10.1016\/j.oooo.2017.10.010_bib0065","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10549-010-0866-3","article-title":"Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer","volume":"122","author":"Guarneri","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.oooo.2017.10.010_bib0070","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.tripleo.2010.04.049","article-title":"Sunitinib may raise the risk of bisphosphonate-related osteonecrosis of the jaw","volume":"110","author":"Hoefert","year":"2010","journal-title":"Oral Surg Oral Med Oral Path Oral Radiol"},{"key":"10.1016\/j.oooo.2017.10.010_bib0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10006-010-0224-y","article-title":"Osteonecrosis of the jaw related to sunitinib","volume":"15","author":"Koch","year":"2011","journal-title":"Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2017.10.010_bib0080","doi-asserted-by":"crossref","first-page":"E81","DOI":"10.21037\/jgo.2016.05.07","article-title":"Osteonecrosis of the jaw associated with ziv-aflibercept","volume":"7","author":"Mawardi","year":"2016","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.oooo.2017.10.010_bib0085","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tripleo.2011.08.024","article-title":"Gingival bleeding and jaw bone necrosis in patients with metastatic renal cell carcinoma receiving sunitinib: report of 2 cases with clinical implications","volume":"113","author":"Nicolatou-Galitis","year":"2012","journal-title":"Oral Surg Oral Med Oral Path Oral Radiol"},{"key":"10.1016\/j.oooo.2017.10.010_bib0090","first-page":"385","article-title":"New non-bisphosphonate drugs that produce osteonecrosis of the jaws","volume":"13","author":"Ramirez","year":"2015","journal-title":"Oral Health Prevent Dent"},{"key":"10.1016\/j.oooo.2017.10.010_bib0095","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.annder.2014.03.009","article-title":"Oral toxicity of targeted anticancer therapies","volume":"141","author":"Sibaud","year":"2014","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.oooo.2017.10.010_bib0100","first-page":"c85","article-title":"Physiology and pharmacology of nonbisphosphonate drugs implicated in osteonecrosis of the jaw","volume":"78","author":"Troeltzch","year":"2012","journal-title":"J Can Dent Assoc"},{"key":"10.1016\/j.oooo.2017.10.010_bib0105","series-title":"Standard Operating Procedures for Bisphosphonate-induced Osteonecrosis of the Jaws","author":"Schiodt","year":"2013"},{"key":"10.1016\/j.oooo.2017.10.010_bib0110","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1016\/j.bjoms.2013.09.008","article-title":"Osteonecrosis of the jaw related to everolimus: a case report","volume":"51","author":"Kim","year":"2013","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2017.10.010_bib0115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3892\/mco.2016.1100","article-title":"Osteonecrosis of the jaw associated with everolimus: a case report","volume":"6","author":"Yamamoto","year":"2017","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.oooo.2017.10.010_bib0120","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5125\/jkaoms.2017.43.2.120","article-title":"A rare case of osteonecrosis of the jaw related to imatinib","volume":"43","author":"Vivano","year":"2017","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"key":"10.1016\/j.oooo.2017.10.010_bib0125","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.oooo.2013.10.010","article-title":"Comparison of nonexposed and exposed bisphosphonate-induced osteonecrosis of the jaws: a retrospective analysis from the Copenhagen cohort and a proposal for an updated classification system","volume":"117","author":"Schiodt","year":"2014","journal-title":"Oral Surg Oral Med Oral Path Oral Radiol"},{"key":"10.1016\/j.oooo.2017.10.010_bib0130","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2147\/CLEP.S71796","article-title":"Existing data sources for clinical epidemiology: Scandinavian Cohort for osteonecrosis of the jaw\u2014work in progress and challenges","volume":"7","author":"Schiodt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.oooo.2017.10.010_bib0135","first-page":"386","article-title":"Guidelines regarding tooth extractions on patients receiving bisphosphonate treatment","volume":"117","author":"Yazdi","year":"2013","journal-title":"Dan Dent J"},{"key":"10.1016\/j.oooo.2017.10.010_bib0140","first-page":"918","article-title":"Medicinrelateret osteonekrose i k\u00e6berne\u2014en oversigt og retningslinier","volume":"119","author":"Schiodt","year":"2015","journal-title":"Dan Dent J"},{"key":"10.1016\/j.oooo.2017.10.010_bib0145","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.oooo.2014.12.024","article-title":"Dentoalveolar trauma and minor trauma as precipitating factors for Medication-related osteonecrosis of the jaw (ONJ): a retrospective study of 149 consecutive patients from the Copenhagen ONJ Cohort","volume":"119","author":"Yazdi","year":"2015","journal-title":"Oral Surg Oral Med Oral Path Oral Radiol"},{"key":"10.1016\/j.oooo.2017.10.010_bib0150","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jcms.2015.03.039","article-title":"Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: a trigger for BRONJ development?","volume":"43","author":"Otto","year":"2015","journal-title":"J Craniomaxillofac Surg"},{"key":"10.1016\/j.oooo.2017.10.010_bib0155","series-title":"Surgical treatment of 141 consecutive patients with medication related osteonecrosis of the jaws (MRONJ) from the Copenhagen ONJ cohort","author":"Schiodt","year":"2016"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440317311495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440317311495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T07:28:07Z","timestamp":1535268487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212440317311495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S2212440317311495"],"URL":"https:\/\/doi.org\/10.1016\/j.oooo.2017.10.010","relation":{},"ISSN":["2212-4403"],"issn-type":[{"value":"2212-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication related osteonecrosis of the jaws associated with targeted therapy as monotherapy and in combination with antiresorptives. A report of 7 cases from the Copenhagen Cohort","name":"articletitle","label":"Article Title"},{"value":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oooo.2017.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}